← FDA Drug Approvals (Drugs@FDA)

XEPI

NDA · New Drug Application · Sponsor: LNHC · Approved 2017-12-11

Drug application

FDA Application #

NDA208945

Application type

New Drug Application

Brand name

XEPI

Generic name

Ozenoxacin

Active ingredients

OZENOXACIN

Dosage form

CREAM

Route

TOPICAL

Marketing status

Discontinued

Sponsor

LNHC

First approval

2017-12-11

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown